1. Home
  2. RCEL vs RGP Comparison

RCEL vs RGP Comparison

Compare RCEL & RGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • RGP
  • Stock Information
  • Founded
  • RCEL N/A
  • RGP 1996
  • Country
  • RCEL United States
  • RGP United States
  • Employees
  • RCEL N/A
  • RGP N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • RGP Business Services
  • Sector
  • RCEL Health Care
  • RGP Consumer Discretionary
  • Exchange
  • RCEL Nasdaq
  • RGP Nasdaq
  • Market Cap
  • RCEL 161.5M
  • RGP 178.9M
  • IPO Year
  • RCEL N/A
  • RGP 2006
  • Fundamental
  • Price
  • RCEL $5.19
  • RGP $5.34
  • Analyst Decision
  • RCEL Strong Buy
  • RGP Sell
  • Analyst Count
  • RCEL 4
  • RGP 1
  • Target Price
  • RCEL $16.50
  • RGP $5.00
  • AVG Volume (30 Days)
  • RCEL 287.8K
  • RGP 190.2K
  • Earning Date
  • RCEL 08-07-2025
  • RGP 07-17-2025
  • Dividend Yield
  • RCEL N/A
  • RGP 9.10%
  • EPS Growth
  • RCEL N/A
  • RGP N/A
  • EPS
  • RCEL N/A
  • RGP N/A
  • Revenue
  • RCEL $71,661,000.00
  • RGP $560,189,000.00
  • Revenue This Year
  • RCEL $57.29
  • RGP N/A
  • Revenue Next Year
  • RCEL $28.07
  • RGP $3.85
  • P/E Ratio
  • RCEL N/A
  • RGP N/A
  • Revenue Growth
  • RCEL 41.35
  • RGP N/A
  • 52 Week Low
  • RCEL $5.10
  • RGP $4.81
  • 52 Week High
  • RCEL $14.16
  • RGP $12.19
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 29.07
  • RGP 48.37
  • Support Level
  • RCEL $5.10
  • RGP $5.38
  • Resistance Level
  • RCEL $6.33
  • RGP $5.70
  • Average True Range (ATR)
  • RCEL 0.32
  • RGP 0.19
  • MACD
  • RCEL 0.02
  • RGP 0.03
  • Stochastic Oscillator
  • RCEL 6.10
  • RGP 44.62

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

Share on Social Networks: